Advertisement
U.S. markets closed

Quince Therapeutics, Inc. (QNCX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.9600-0.1200 (-5.77%)
At close: 04:00PM EST
2.0400 +0.08 (+4.08%)
After hours: 07:58PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 86.24M
Enterprise Value 53.85M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.92
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.44

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3110.75%
S&P500 52-Week Change 331.18%
52 Week High 32.4500
52 Week Low 30.5120
50-Day Moving Average 31.1257
200-Day Moving Average 30.9609

Share Statistics

Avg Vol (3 month) 3524.06k
Avg Vol (10 day) 3423.63k
Shares Outstanding 544M
Implied Shares Outstanding 644.76M
Float 834.6M
% Held by Insiders 113.74%
% Held by Institutions 125.53%
Shares Short (Oct 31, 2024) 42.35M
Short Ratio (Oct 31, 2024) 42.27
Short % of Float (Oct 31, 2024) 45.86%
Short % of Shares Outstanding (Oct 31, 2024) 45.42%
Shares Short (prior month Sep 30, 2024) 41.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.50%
Return on Equity (ttm)-79.38%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -29.13M
Net Income Avi to Common (ttm)-53.12M
Diluted EPS (ttm)-1.2400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.45M
Total Cash Per Share (mrq)1.37
Total Debt (mrq)14.38M
Total Debt/Equity (mrq)30.62%
Current Ratio (mrq)6.15
Book Value Per Share (mrq)1.98

Cash Flow Statement

Operating Cash Flow (ttm)-27.99M
Levered Free Cash Flow (ttm)-7.84M